A Phase 1/2 interventional study of Child and Family Traumatic Stress Interv (CFTSI) and Psychoeducational Comparison in Posttraumatic Stress Disorder, sponsored by Yale University. Completed at 1 site in United States. Open to participants aged 7 Years to 17 Years. Per ClinicalTrials.gov, last updated 2011-06-16.
Sponsored by Yale University · Phase 1/2, Interventional, and Prevention
The purpose of this study is to determine the efficacy of the Child and Family Traumatic Stress Intervention (CFTSI) in preventing the development of Posttraumatic Stress Disorder (PTSD) when implemented within 30 days of a potentially traumatic event.
2,239 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 554 are open to participants now.
This study's enrollment of 112 is above the median of 70 across 1,858 interventional studies indexed under Stress Disorders, Post-Traumatic.
Browse Stress Disorders, Post-Traumatic studies →Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.
Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
4-session secondary prevention model that focuses on family communication about symptoms of a child aged 7-16.
Behavioral: Child and Family Traumatic Stress Interv (CFTSI)
4-sessions focused on individual child using psychoeducation and relaxation skills
Behavioral: Psychoeducational Comparison
4 sessions involving both the target child and a parent/caregiver
4 individually focused sessions including psychoeducation and relaxation.
UCLA Posttraumatic Reaction Index (PTSD-RI)
Time frame: 3 months post-intervention
Trauma Symptom Checklist for Children (TSCC)
Time frame: 3 Months post-intervention
This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stress Disorders, Post-Traumatic→
Yale University